<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Differentiated thyroid cancer":3,
"lenvatinib":4,
"tyrosine kinase inhibitor":3,
"oncology":2,
"papillary microcarcinoma":3,
"risk":1,
"thyroid cancer":22,
"treatment decision making":1,
"uncertainty":1,
"Costs and cost analysis":1,
"Diagnostic techniques and procedures":1,
"Thyroid neoplasms":5,
"Ultrasonography":5,
"Breast cancer screening":1,
"Breast ultrasound":1,
"Recall criteria":1,
"Ultrasonographic screening":1,
"Annexin A6":1,
"Bisphenol A":1,
"Endocrine disruptors":1,
"Maternal exposure":1,
"Proteomics":1,
"Valosin-containing protein":1,
"Women":2,
"Autoimmune diseases":1,
"Good's syndrome":1,
"Lupus systémique":1,
"Maladies auto-immunes":1,
"Polymyosite":1,
"Polymyositis":1,
"Syndrome de Good":1,
"Systemic lupus":1,
"Thymoma":1,
"Thymome":1,
"Adjuvant chemotherapy":1,
"Breast neoplasms":1,
"Cardiotoxicity":1,
"Dexrazoxane":1,
"Trastuzumab":1,
"APC mutation":1,
"Extracolonic cancer":1,
"FAP":1,
"Familial adenomatous polyposis":2,
"(131)I SPECT/TC":1,
"Carcinoma diferenciado de tiroides":1,
"Elastofibroma dorsi":1,
"False positive scan":1,
"Falso positivo scan":1,
"I-131 SPECT/CT":1,
"Radioiodine":1,
"Radioyodo":1,
"ALOPECIA":1,
"GLIOBLASTOMA MULTIFORME":1,
"HISTONE H3K9 DEMETHYLASE":1,
"JmjC DOMAIN":1,
"SOMATIC MUTATION":1,
"ARFI":1,
"Elastography":2,
"Parathyroid":1,
"Thyroid":18,
"Ultrasound":7,
"breast cancer":10,
"cancer susceptibility gene":1,
"microfluidic PCR":1,
"mutation":2,
"next-generation sequencing":1,
"core needle biopsy":1,
"diagnosis":2,
"neoplasm":2,
"pathology":1,
"thyroid nodule":9,
"active surveillance":1,
"medical cost":1,
"risk classification":1,
"surgery":3,
"unfavorable events":1,
"AKT":1,
"Oncogene-induced senescence":1,
"RET oncogene":1,
"epidemiology":2,
"hypothyroidism":1,
"thyroidectomy":4,
"thyroxin":1,
"interobserver variability":1,
"intraobserver variability":1,
"measurement":1,
"thyroid/parathyroid":1,
"AJCC staging":1,
"extrathyroidal extension":1,
"lymphovascular invasion":1,
"HIFU":1,
"thermal ablation":2,
"Bethesda":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":3,
"thyroid gland":3,
"thyroid neoplasm":1,
"Hashimoto's disease":1,
"lymph node dissection":1,
"lymph nodes":3,
"metastasis":5,
"outcomes assessment":1,
"prognostic factors":1,
"c-Met":1,
"cabozantinib":1,
"radiopharmaceutical":1,
"Computed tomography":2,
"Major salivary gland":1,
"Papillary thyroid carcinoma":14,
"Radioactive iodine ablation":1,
"Bethesda system":1,
"malignancy":3,
"risk of malignancy (ROM)":1,
"thyroid nodules":3,
"decision support":1,
"standardized reporting":1,
"Chernobyl":1,
"Fukushima":1,
"radiation exposure":1,
"thyroid surgery":2,
"ultrasound thyroid screening":1,
"Case report":1,
"endocrine gland":1,
"fluorodeoxyglucose positron emission tomography":1,
"small-cell lung carcinoma":1,
"American Thyroid Association":2,
"Children":1,
"Thyroid Image Reporting and Data System":1,
"Thyroid carcinoma":12,
"ATP synthase":1,
"ATP6":1,
"Cancer":7,
"Mitochondria":1,
"OM45":1,
"Permeability transition":1,
"18F-DOPA PET/CT":1,
"Medullary thyroid carcinoma":2,
"Prognostic value":1,
"Restaging":1,
"Cancer therapy":1,
"Clinical management":1,
"Diabetes":1,
"Diabetes therapy":1,
"Carcinoma, papillary":1,
"Neoplasm metastasis":3,
"Programmed death-ligand 1":1,
"BRAF mutation":4,
"noninvasive follicular variant of papillary thyroid carcinoma":1,
"pediatric thyroid lesions":1,
"Adenoma":1,
"MLH1":1,
"MSH2":1,
"MSH6":1,
"polyp":1,
"tumour":1,
"S-1":1,
"chemotherapy":5,
"cisplatin":1,
"unknown primary origin":1,
"over detection":1,
"calcitonin":1,
"elective neck dissection":1,
"observation":1,
"regional metastases":1,
"free iodide":1,
"iodide uptake":1,
"iodinated contrast media":1,
"salivary glands":1,
"Breast-conserving surgical procedures":1,
"CT contrast":1,
"Radioiodination":1,
"Radiopaque fiducial marker":1,
"biomarker":4,
"chromogranin A":1,
"neuroendocrine neoplasm":1,
"prognosis":3,
"response to treatment":1,
"BRAFV600E mutation":1,
"Central lymph node metastasis":1,
"Multifocality":1,
"Prophylactic lymph node dissection":1,
"fine needle aspiration cytology":3,
"hyperparathyroidism":1,
"parathyroid carcinoma":1,
"CD20":1,
"Immunohistochemistry":5,
"anaplastic carcinoma":1,
"cancer genome":1,
"follicular carcinoma":1,
"papillary carcinoma":5,
"Cell line":1,
"Lung adenocarcinoma":1,
"Micropapillary":1,
"Molecular":2,
"Papillary":3,
"American Joint Committee on Cancer (AJCC)":1,
"anaplastic":2,
"staging":1,
"Schwannoma":1,
"TTF-1":1,
"Transcriptional activation":1,
"mRNA":1,
"qPCR":1,
"oncogene testing":1,
"pediatric thyroid cancer":1,
"Bone metastases":3,
"Denosumab-radioiodine":1,
"Zoledronate":1,
"WhatsApp":1,
"cytopathology":1,
"smartphone":1,
"static image":1,
"telecytology":1,
"lymph node ratio":1,
"lymph node yield":1,
"nodal metastasis":1,
"recurrence":2,
"chyle leakage":1,
"conservative management":1,
"dietary modification":1,
"thoracic duct ligation":1,
"carcinoma":6,
"carcinoma showing thymus-like elements (CASTLE)":1,
"genetic analysis":1,
"parotid":1,
"thymus-like differentiation":1,
"Neck Dissection":1,
"Abscess":1,
"Drainage":1,
"Guideline":1,
"Metastases":1,
"Percutaneous ablation":1,
"Safety":1,
"Ultrasound guidance":1,
"maximum standardized uptake value (SUVmax)":1,
"positron emission tomography (PET)/CT":1,
"recurrent thyroid cancer":1,
"serum thyroglobulin (Tg)":1,
"thyroglobulin antibody (TgAb)":1,
"Kidney":1,
"Drug resistance mutant":1,
"Medullary thyroid cancer":1,
"RET kinase":1,
"Structure-activity relationship":1,
"endocrine cancers":1,
"rare diseases/syndromes":1,
"CRKL":1,
"HDAC inhibitor":1,
"MiR-200c":1,
"SAHA":2,
"childbearing":1,
"postpartum":1,
"pregnancy":1,
"dabrafenib":2,
"trametinib":2,
"undifferentiated":2,
"hyperthyroidism":3,
"radioiodine therapy":1,
"radioiodine thyroid uptake":1,
"reproducibility":1,
"aggressive behavior":1,
"hobnail variant":1,
"Invasion":1,
"Strap muscle":1,
"Voice":1,
"SDS":1,
"globus symptoms":1,
"quality of life":2,
"Follicular variant":2,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Proliferation":1,
"SNHG15":1,
"miR-211-3p":1,
"Combination anticancer chemotherapy":1,
"Energy metabolism":1,
"Glyoxalase I":1,
"Inhibitor":1,
"Pyruvate kinase M2":1,
"The Warburg effect":1,
"TROP2":1,
"Lymph node metastases":1,
"Microcarcinoma":1,
"Survival rate":2,
"cohort study":1,
"exercise treadmill test":1,
"heart rate recovery":1,
"NIFTP":2,
"follicular variant of papillary thyroid carcinoma":1,
"anaplastic thyroid carcinoma":1,
"follicular thyroid carcinoma":2,
"molecular pathology":1,
"poorly differentiated thyroid carcinoma":1,
"thyroid markers":1,
"thyroid tumours":1,
"familial medullary thyroid carcinoma":1,
"familial non-medullary thyroid carcinoma":1,
"familial thyroid carcinoma":1,
"multiple endocrine neoplasia":1,
"poorly differentiated":1,
"rare tumour":1,
"unusual tumour":1,
"Adrenocortical insufficiency":1,
"Adrenocorticotropic hormone":1,
"Cushing’s syndrome":1,
"Hyperaldosteronism, primary":1,
"Pheochromocytoma":1,
"BRAFV600E":1,
"Bortezomib":1,
"NF-κB":1,
"Vemurafenib":2,
"Aldehyde dehydrogenase":1,
"Cancer stem cells":1,
"Patient-derived xenograft tumor":1,
"Primary cells":1,
"Subpopulations of cancer stem cells":1,
"EZH2":1,
"epigenetics":1,
"prognostic factor":1,
"EMT":1,
"Tiam1":1,
"Wnt/β-catenin signaling":1,
"Pyruvate kinase":2,
"ovarian cancer":1,
"CT density change":1,
"head and neck cancer":2,
"radiation therapy":1,
"thyroid function":1,
"Inter-exam agreement":1,
"K-TIRADS":1,
"HuR":1,
"RNA-binding proteins":1,
"anaplastic thyroid cancer":2,
"siRNA":1,
"YAP":1,
"ZEB1":1,
"hTERT":1,
"Immune-related adverse events (irAEs)":1,
"Nivolumab":2,
"Non-small-cell lung cancer (NSCLC)":1,
"FTC":1,
"gene expression":2,
"minimally invasive":1,
"bone microenvironment":2,
"bone tropism":1,
"molecular mechanisms":1,
"therapeutic strategies":1,
"Chronic lymphocytic thyroiditis":1,
"C1QL1":1,
"CILP":1,
"CRABP1":1,
"LCN2":1,
"RNA sequencing":1,
"TCGA":1,
"3D–printed titanium sternum":1,
"Sternal tumor":1,
"Sternectomy":1,
"Aggressive features":1,
"Expression":1,
"PTC":1,
"VHL":1,
"miR-92a":1,
"cell proliferation":2,
"isoenzyme":1,
"lapatinib":1,
"Bone metastasis":1,
"IL-11":1,
"miR-124":1,
"Age-related cancer risk":1,
"Histologic features":1,
"Metastatic diffusion":1,
"Phenotypical expression":1,
"Thyroid cancer presentation":1,
"autoimmune":1,
"fulminant type 1 diabetes mellitus":1,
"immune checkpoint inhibitor":1,
"painless thyroiditis":1,
"WGCNA":1,
"competing endogenous RNA":1,
"differentially expressed RNAs":1,
"long non-coding RNA":1,
"regulatory network":1,
"FNA":1,
"Fine needle aspiration":1,
"Follow-up":1,
"Intervention":1,
"Nodule":1,
"Prospective study":1,
"Radiofrequency ablation":1,
"Tumor":1,
"Benign thyroid nodule":1,
"Laser":1,
"Laser ablation":1,
"Graves’ disease":2,
"aloperine":1,
"apoptosis":1,
"Cancer registry":1,
"China":1,
"Incidence":1,
"Malignant tumor":1,
"Mortality":2,
"cirrhosis":1,
"drugs and medicines":1,
"immunology":1,
"radiology":1,
"Body mass index":1,
"Central obesity":1,
"Overweight":1,
"Waist circumference":1,
"IgG4-related disease":1,
"Mass-forming thyroiditis":1,
"Regional lymphadenopathy":1,
"brain metastases":1,
"disease outcome":1,
"distant metastases":1,
"non-medullary":1,
"angiopoietin 1":1,
"angiopoietin receptor":1,
"phosphoinositide-3 kinase/RAC serine/threonine-protein kinase pathway":1,
"incidental findings":1,
"18 F-FDG-PET CT scan":1,
"Cystic neck lesion":1,
"FNAC":1,
"Squamous cell carcinoma":1,
"Therapeutics":1,
"Dose reduction":1,
"Hypertension":2,
"Targeted therapy":3,
"NCOA5":1,
"lymph node metastasis":1,
"Nasal cavity":1,
"stimulated serum thyroglobulin":1,
"unstimulated serum thyroglobulin":1,
"PRRT":1,
"mutations":2,
"peptide receptor radionuclide therapy":1,
"WW domain-containing transcription regulator protein 1":1,
"miR-144":1,
"papillary thyroid cancer":3,
"tumor sizes":1,
"Agarose cell block":1,
"HBME-1":1,
"fine-needle aspirate":1,
"galectin-3":1,
"thyroid tumors":2,
"advanced medullary thyroid carcinoma":1,
"apatinib":1,
"tyrosine kinase inhibitors":1,
"adrenal oncocytoma":1,
"concomitant neoplasia":1,
"functional adrenal neoplasm":1,
"hereditary cancer syndrome":1,
"Hepatitis B virus":1,
"Hepatitis C virus":1,
"Occupation":1,
"Parathyroid adenoma":1,
"Parathyroids":1,
"Shear wave elastography":1,
"sistrunk procedure":1,
"thyroglossal duct cyst":1,
"CD56":1,
"fine-needle aspiration cytology":1,
"immunocytochemistry":2,
"suspicion":1,
"PSMA":1,
"prostate cancer":1,
"tumor neoangiogenesis":1,
"RET":1,
"genetic instability":1,
"tumor clonality":1,
"cancer immunotherapy":1,
"granzyme A":1,
"immune cytolytic activity":1,
"perforin 1":1,
"tumor-associated neutrophils":1,
"tumor-infiltrating lymphocytes":1,
"Carcinoma thyroid":1,
"lymph node":1,
"matrix metalloproteinases":1,
"orbithopathy":1,
"tissue inhibitors of metalloproteinases":1,
"CST6":1,
"Cystatin E/M":1,
"Triple-negative breast cancer":1,
"progress":1,
"fine needle aspiration cystic fluid":1,
"proteome profiles":1,
"secretome":1,
"Meta-analysis":1,
"Positron emission tomography":1,
"Systematic review":1,
"Cowden syndrome":1,
"DICER1 syndrome":1,
"Hereditary":1,
"PTEN":2,
"Infarction after biopsi":1,
"synchronous tumor":1,
"thyroid papillary carcinoma":2,
"Histopathology":1,
"retrospective":1,
"thyroid diseases":1,
"ASPH":1,
"Invasive breast cancer":1,
"Methylation":1,
"Malignant pleural mesothelioma":1,
"antibody":1,
"calretinin, mesothelin":1,
"BISPR":1,
"Bcl-2":1,
"miR-21-5p":1,
"Graves´ disease":1,
"nuclear medicine":1,
"Complications":1,
"goiter":1,
"retrosternal goiter":2,
"ESCC":1,
"PKM2":1,
"glycolysis":1,
"mTOR":1,
"B-type Raf (BRAF)":1,
"Missed thyroid gland":1,
"substernal goiter":1,
"total thyroidectomy":1,
"hyalinizing trabecular tumor":1,
"trabecular pattern":1,
"KIT":1,
"PD-1":1,
"immune":1,
"radiotherapy":1,
"Complication":1,
"survival":2,
"I-131 therapy":1,
"management":1,
"pediatric cancer":1,
"thyroid caricinoma":1,
"Hyperspectral imaging":1,
"convolutional neural network":1,
"deep learning":1,
"head and neck surgery":1,
"intraoperative imaging":1,
"optical biopsy":1,
"Cavernous hemangioma":1,
"Ground-glass nodule":1,
"Solitary pulmonary capillary hemangioma":1,
"EG7":1,
"EL4":1,
"cyclophosphamide":1,
"immunotherapy":1,
"lymphoma":1,
"NRAS":1,
"miR-22":1,
"paclitaxel":1,
"tumor suppressor":1,
"ectopic meningioma":1,
"lung neoplasm":1,
"primary pulmonary meningioma":1,
"quality assurance":1,
"Central composite design":1,
"Chemometric tools":1,
"Metabolomics":1,
"Urine":1,
"Differential diagnosis":1,
"Large":1,
"Poor":1,
"circulating tumor cells (CTCs)":1,
"differentiated thyroid carcinoma (DTC)":1,
"minimally invasive follicular thyroid carcinoma (MIFC)":1,
"risk stratification":1,
"Duplex Doppler ultrasonography":1,
"Vascular resistance":1,
"BRAF":1,
"NTRK":1,
"dedifferentiated":1,
"sarcomatoid":1,
"squamous":1,
"Hürthle cell":1,
"Metabolism":1,
"glycine":1,
"serine":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年1月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
